Portfoliotracker

PMV Pharmaceuticals, Inc.

PMVP · NASDAQGS · Healthcare Biotechnology 19/100 E

1,190 $
▼ −0,080 (−6,30 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 12:12
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score19 / 100 Market cap67,3 mil. $ P/E– Forward P/E-1,4 P/S– P/B0,9 EV/EBITDA– Dividend yield– FCF yield-105,96 % EPS-1,56 $ Net margin0,0 % Return on equity-99,4 % Beta– Debt / equity0,00
52-week range 1,02 to 1,91
3-month average volume0,7 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Employees
54
Country
United States
Fiscal year end
31. 12.
Data since
25. 9. 2020

Explore further

Similar companies PRLDALXONKTXZNTLCCCC

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account